Mark Pino

Mark Pino

Mintz

Contact
View Bio
RSS

Latest Posts › Bristol-Myers Squibb

Share:

District of Delaware Dismisses ANDA Applicant for Lack of Venue under TC Heartland

On October 18, 2018, the United States District Court for the District of Delaware, in Bristol-Myers Squibb v. Mylan Pharmaceuticals Inc., No. 17-00379, held that venue was not proper in Delaware over Mylan Pharmaceuticals...more

10/24/2018  /  Abbreviated New Drug Application (ANDA) , Bristol-Myers Squibb , Hatch-Waxman , Improper Venue , Mylan Pharmaceuticals , Patent Infringement , Patent Litigation , Pharmaceutical Patents , TC Heartland LLC v Kraft Foods , Venue
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide